Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Observation and Interactions Between Cardio-respiratory and Motor Transitions During Maximal Incremental Exercise Test on Elliptical Bike and Running Treadmill.

4 novembre 2026 aggiornato da: University Hospital, Grenoble

Observation et Mise en Relation Des Transitions Cardio-respiratoires et Motrices Lors d'un Exercice incrémental Maximal.

For safety considerations and to ensure the effectiveness of physical activity within a rehabilitation programme, it is important to establish an appropriate exercise intensity to achieve the programme's objectives. This requires identifying individualised exercise intensity zones that are specifically tailored to each patient, in order to design an effective and progressive exercise training programme.

Exercise prescription is based on four principles: frequency, duration, volume, and intensity. The first three factors are relatively easy to adjust when planning a training programme, whereas exercise intensity is based on a concept that is more difficult to assess and control. On the one hand, exercise intensity is more complex to measure; on the other, establishing individualised reference points and guidelines tailored to each patient is not straightforward.

It is now well established that ventilatory transitions are individualised physiological markers that delineate exercise intensity zones. These transition markers provide valuable reference points for exercise training, helping to ensure that physical activity is both safe and sufficiently intense to induce beneficial physiological adaptations in patients.

Within this rehabilitation context, the aim of the present study is to identify markers of these two physiological transitions during a maximal exercise test conducted under laboratory conditions. The study seeks to identify non-invasive markers related to cardiovascular, respiratory, and motor responses, with a view to conducting similar assessments under real-world conditions in the future. A database has already been established using cycle ergometry (the CAREMO protocol). The next step is to build a new database based on maximal exercise testing, this time using two different exercise modalities: the elliptical trainer and the treadmill. In addition to the new challenge of investigating the second ventilatory transition, the less constrained movement patterns associated with these exercise modalities require adaptations to the analysis methods in order to continue identifying changes in motor behaviour.

Panoramica dello studio

Stato

Non ancora reclutamento

Descrizione dettagliata

There are currently no accessible physiological datasets combining synchronised motor data (motion analysis) and cardiorespiratory data (ECG, gas exchange analysis, and spirometry) in humans during exercise on an elliptical trainer or a treadmill.

The work conducted as part of this study will focus on acquiring data from wearable inertial measurement units (IMUs) to assess motor behaviour, cardiac measurements, and laboratory measurements required to determine the first and second ventilatory thresholds (VT1 and VT2) using gas exchange analysis, across both exercise modalities.

To this end, 20 participants will take part in two sessions involving a maximal incremental exercise test. The two sessions will be scheduled between one and fifteen days apart. The first session will involve exercise on a treadmill, while the second will involve exercise on an elliptical trainer.

The signals recorded during the study may contribute to a better understanding of the relationship between cardiorespiratory physiology and motor behaviour during exercise.

For example, as outlined in the secondary objectives of the study, these signals may be used to develop new algorithms for defining criteria to assess motor transitions.

The following hypotheses will be investigated:

  • This study will enable the creation of a database containing synchronised, non-invasive cardiorespiratory and motor behaviour signals.
  • The questionnaire will allow the assessment of differences in the impact of each piece of exercise equipment on participants' comfort during exercise.
  • The database will enable the analysis of relationships between motor and cardiorespiratory data during physical activity, particularly as participants cross the two physiological thresholds (VT1 and VT2).

Tipo di studio

Osservativo

Iscrizione (Stimato)

20

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Backup dei contatti dello studio

Luoghi di studio

      • Grenoble, Francia, 38043
        • CHU Grenoble Alpes - Hopital Sud
        • Contatto:

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 18 anni a 64 anni (Adulto)

Accetta volontari sani

Sì

Sessi ammissibili allo studio

Tutto

Metodo di campionamento

Campione non probabilistico

Popolazione di studio

Healthy volunteers

Descrizione

Inclusion Criteria:

  • Men and women of 18 to 64 y-old
  • Subject able to run on a treadmill and bike on an elliptical bike for 20minutes
  • No contraindications to participating in physical exercise.
  • No chronic cardiac or respiratory conditions.
  • No locomotor disorders affecting the spine or lower limbs that are incompatible with physical activity.
  • No recent injuries (within the previous two months) that would prevent participation in physical activity.
  • Affiliation with a social security scheme.

Exclusion Criteria:

  • Pregnant women (as determined by a urine pregnancy test) and breastfeeding women.
  • Use of medication likely to significantly interfere with heart rate regulation, as assessed by the principal investigator.
  • Individuals falling within the categories specified in Articles L. 1121-5 to L. 1121-8 of the French Public Health Code (Code de la santé publique). These include protected individuals, namely pregnant women, women in labour, breastfeeding mothers, individuals deprived of their liberty by judicial or administrative decision, individuals receiving psychiatric care under Articles L. 3212-1 and L. 3213-1 who do not fall under the provisions of Article L. 1121-8, individuals admitted to a healthcare or social care facility for purposes other than research, minors, and individuals subject to a legal protection measure or unable to express their consent.
  • Personnel who have a hierarchical relationship with the principal investigator.
  • Individuals currently subject to an exclusion period from another study.
  • Individuals who would receive more than €6,000 in compensation for their participation in other research involving human participants during the 12 months preceding this study.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Modelli osservazionali: COHORT
  • Prospettive temporali: PROSPECTIVE

Coorti e interventi

Gruppo / Coorte
Intervento / Trattamento
Volontari sani

Incremental exercise tests on treadmill

Incremental exercise tests on elliptical bike

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Inertial Measurement Units
Lasso di tempo: 20 minutes of exercise test

Measured with Inertial Measurement Units (IMU), placed on the pelvis, the thighs and the shanks.

Time series collected at 60Hz, with 3 axis Accelerations (m/s²), 3 axis Gyroscops (rad/s) Data are timestamped and synchronized with the world clock

20 minutes of exercise test
Gas Analysis
Lasso di tempo: 20 minutes of exercise test

Gas analyser measurements, (VO2 (L/min), VCO2 (L/min), PetO2 (mmHg), PetCO2 (mmHg), VE (L/min) Measures are timestamped, and saved breath-by-breath Data are timestamped and synchronized with the world clock

20 minutes of exercise test
Rate of Perceived Exertion (RPE)
Lasso di tempo: 20 minutes of exercise test

RPE, also named BORG scale rates perceived exertion on a scale from 6 to 20.

1 measurement per min Data are timestamped and synchronized with the world clock

20 minutes of exercise test
Ergometer
Lasso di tempo: 20 minutes of exercise test

Running Treadmill, or Elliptical bike

Data collected are the following (1Hz):

Cadence, Human Power or Speed Data are timestamped and synchronized with the world clock

20 minutes of exercise test

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Pubblicazioni generali

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

15 novembre 2026

Completamento primario (Stimato)

15 gennaio 2027

Completamento dello studio (Stimato)

31 gennaio 2027

Date di iscrizione allo studio

Primo inviato

27 ottobre 2026

Primo inviato che soddisfa i criteri di controllo qualità

4 novembre 2026

Primo Inserito (Effettivo)

10 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

10 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

4 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

INDECISO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi